Less Ads, More Data, More Tools Register for FREE

Pin to quick picksCrossword Cybersecurity Regulatory News (CCS)

  • This share is currently suspended. It was suspended at a price of 1.75
  • There is currently no data for CCS

Director's Shareholding

22 Apr 2009 07:00

RNS Number : 9424Q
Clarity Commerce Solutions PLC
22 April 2009
 



CCS.L

Clarity Commerce Solutions plc

("Clarity" or the "Company")

Director's shareholding

Clarity announces that it was informed on 21 April 2009 that on the same daythe following directors purchased 60,000 ordinary shares of 25p each in the capital of the Company ("Ordinary Shares"), at 29.75 pence per share:

Total interest following purchase

Ordinary Shares purchase

Number

Percentage of issued share capital

John O'Hara (Non-executive Chairman)

20,000

705,775

2.20%

Sir Colin Chandler (Deputy Non-executive Chairman)

20,000

334,022

1.04%

Ken Smith (Chief Executive)

20,000

320,000

0.99%

For further information, please contact:

Clarity Commerce Solutions plc

Ken Smith, CEO

01256 365 150

Arbuthnot Securities Limited

Alasdair Younie/Ben Wells

020 7012 2000

Biddicks

Shane Dolan

020 7448 1000

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
RDSEAKLFASENEFE
Date   Source Headline
22nd Oct 20207:00 amRNSCrossword accepted onto G-Cloud framework
20th Oct 20209:26 amRNSGrant of Options to Directors and Employees
5th Oct 20207:05 amRNSTom Ilube appointed to WPP Board
28th Sep 20207:00 amRNSHalf-year Report
24th Sep 20202:00 pmRNSNotice of Results and Investor Presentation
3rd Aug 20207:00 amRNSTrading Update
16th Jul 202012:00 pmRNSLaunch of Rizikon Pro
18th Jun 20204:04 pmRNSGrant of Options
8th Jun 20207:00 amRNSNew Consulting contract
28th May 20202:30 pmRNSResult of AGM
5th May 20205:41 pmRNSHolding(s) in Company
28th Apr 20202:00 pmRNSDirector Shareholding - Replacement
27th Apr 20201:10 pmRNSDirector Shareholding - Replacement
27th Apr 202011:45 amRNSDirector Shareholding
27th Apr 202011:05 amRNSDirector/PDMR Shareholding
27th Apr 202010:21 amRNSDirector's subscription completes £1m fundraise
27th Apr 20207:00 amRNS2019 Annual Report and Accounts
20th Apr 20207:00 amRNSPlacing to raise £1m
6th Apr 20207:00 amRNSNew partner announced for Rizikon Assurance
26th Mar 20207:00 amRNSCrossword issues working from home guidance
17th Mar 20207:00 amRNSBarron McCann to use Rizikon Assurance
12th Mar 20209:56 amRNSCrossword Consulting Long Term Incentive Plan
12th Mar 20207:00 amRNSConsulting Division signs new agreements
10th Mar 20207:00 amRNSRizikon Assurance to support Cammell Laird
5th Mar 20202:02 pmRNSDirector/PDMR Shareholding
10th Feb 20207:00 amRNSTrading Update
17th Jan 20207:00 amRNSExercise of options
7th Jan 202012:27 pmRNSAdditional Loan Agreement
7th Jan 20207:00 amRNSSenior management changes
20th Dec 20198:15 amRNSExercise of options
10th Dec 20194:04 pmRNSResult of General Meeting
5th Dec 20197:00 amRNSCREST Penetration Testing Provider Approval
29th Nov 20198:15 amRNSGrant of Options to Director and Employees
26th Nov 20197:00 amRNSConsulting Gains Traction Across Industry Sectors
22nd Nov 20195:47 pmRNSPublication of Circular
21st Nov 20197:00 amRNSNotice of General Meeting
14th Nov 20197:00 amRNSCrossword introduces Nixer CyberML
13th Nov 20197:00 amRNSTom Ilube Influential BAME Tech Leader Recognition
31st Oct 20197:00 amRNSNew partner for Rizikon Assurance portal
24th Oct 201910:16 amRNSTrading Update and Financing
23rd Oct 20197:00 amRNSCrossword sponsoring CIPS UK Conference 2019
15th Oct 20197:00 amRNSAgreement with Global Aerospace Security Company
8th Oct 20197:00 amRNSFTSE 250 company to use Rizikon Assurance
7th Oct 20197:00 amRNSCrossword team members included in Progress 1000
23rd Sep 20197:00 amRNSHalf-year Report
4th Sep 20197:00 amRNSRizikon Assurance 2.0
9th Aug 201911:00 amRNSTrading Update
6th Aug 20197:00 amRNSCouncils to use Rizikon Assurance
27th Jun 20197:00 amRNSNursing & Midwifery Council to use Rizikon
5th Jun 20197:00 amRNSIssue of Options to Employees and Directors

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.